Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with somatostatin receptor expressing neuroendocrine tumors six years' assessment
Mohammadali Hamiditabar, Muzammil Ali, Joseph Roys, Edward M. Wolin, Thomas M. O'Dorisio, David Ranganathan, Izabela Tworowska, Jonathan R. Strosberg, Ebrahim S. Delpassand
Dive into the research topics of 'Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with somatostatin receptor expressing neuroendocrine tumors six years' assessment'. Together they form a unique fingerprint.